Gastroenterology Doctors in Flagstaff, AZ Accepting Medicare

4 Gastroenterology doctors found. Showing 1 - 4

Dr. Steven L Palley, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 77 W Forest Ave, Ste. 210, Flagstaff, AZ 86001 Phone: 928-773-2547    Fax: 328-773-2548

Dr. Joan C Mitrius, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 77 W Forest Ave, Ste 210, Flagstaff, AZ 86001 Phone: 928-773-2547    Fax: 928-773-2548

Dr. Michael Angelo Trujillo, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 77 W Forest Ave, Ste 210, Flagstaff, AZ 86001 Phone: 928-773-2547    Fax: 928-773-2548

Andrew James Overhiser, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1215 N Beaver St, Flagstaff, AZ 86001 Phone: 928-773-2200    Fax: 928-773-2300

News Archive

WHO and UNICEF have announced a global reduction of 30% in deaths from measles between 1999 and 2002

The World Health Organization (WHO) and the United Nation's Children's Fund (UNICEF) today announced a global reduction of 30% in deaths from measles between 1999 and 2002. At 35%, the reduction in measles deaths was even greater in Africa, the region with the highest number of people affected by the disease.

Gamma Pharmaceuticals completes the registration of six of its Brand Trademarks in China

Gamma Pharmaceuticals Inc. (the "Company") announced it has successfully completed the registration of six of the Company's Brand Trademarks with The State Trademark Bureau of China.

BIDMC physician-scientist receives Young Investigator Award to research on prostate cancer

Akash Patnaik, MD, PhD, a physician-scientist in the Hematology/Oncology Divison at Beth Israel Deaconess Medical Center and Instructor of Medicine at Harvard Medical School has received a Young Investigator Award from The Prostate Cancer Foundation. The three-year $225,000 award, one of 21 made to young scientists from across the U.S. and Canada, is designed to encourage the most innovative minds in cancer research to focus their careers on prostate cancer.

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.

Read more Medical News

› Verified 7 days ago